nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—MMP9—multiple sclerosis	0.422	0.782	CbGaD
Captopril—ALB—multiple sclerosis	0.117	0.218	CbGaD
Captopril—CYP2D6—Fingolimod—multiple sclerosis	0.0339	0.171	CbGbCtD
Captopril—ALB—Prednisone—multiple sclerosis	0.0268	0.135	CbGbCtD
Captopril—ABCB1—Methylprednisolone—multiple sclerosis	0.0232	0.117	CbGbCtD
Captopril—ABCB1—Mitoxantrone—multiple sclerosis	0.0169	0.0853	CbGbCtD
Captopril—SLC22A6—Methotrexate—multiple sclerosis	0.0158	0.0798	CbGbCtD
Captopril—ABCB1—Betamethasone—multiple sclerosis	0.0151	0.0761	CbGbCtD
Captopril—ABCB1—Prednisolone—multiple sclerosis	0.0149	0.075	CbGbCtD
Captopril—ABCB1—Prednisone—multiple sclerosis	0.014	0.0709	CbGbCtD
Captopril—ALB—Methotrexate—multiple sclerosis	0.0135	0.068	CbGbCtD
Captopril—ABCB1—Dexamethasone—multiple sclerosis	0.00876	0.0442	CbGbCtD
Captopril—CYP2D6—Dexamethasone—multiple sclerosis	0.00826	0.0417	CbGbCtD
Captopril—ABCB1—Methotrexate—multiple sclerosis	0.00704	0.0356	CbGbCtD
Captopril—F2—leg—multiple sclerosis	0.00584	0.101	CbGeAlD
Captopril—REN—peripheral nervous system—multiple sclerosis	0.00583	0.101	CbGeAlD
Captopril—REN—nerve—multiple sclerosis	0.00454	0.0789	CbGeAlD
Captopril—ACE—peripheral nervous system—multiple sclerosis	0.00248	0.0431	CbGeAlD
Captopril—LTA4H—retina—multiple sclerosis	0.00244	0.0424	CbGeAlD
Captopril—REN—brainstem—multiple sclerosis	0.00195	0.0339	CbGeAlD
Captopril—ACE—nerve—multiple sclerosis	0.00194	0.0336	CbGeAlD
Captopril—LTA4H—medulla oblongata—multiple sclerosis	0.00176	0.0306	CbGeAlD
Captopril—MMP2—retina—multiple sclerosis	0.00173	0.03	CbGeAlD
Captopril—LTA4H—midbrain—multiple sclerosis	0.00161	0.028	CbGeAlD
Captopril—LTA4H—spinal cord—multiple sclerosis	0.00157	0.0273	CbGeAlD
Captopril—LTA4H—nervous system—multiple sclerosis	0.00132	0.023	CbGeAlD
Captopril—LTA4H—central nervous system—multiple sclerosis	0.00127	0.0221	CbGeAlD
Captopril—MMP2—medulla oblongata—multiple sclerosis	0.00125	0.0217	CbGeAlD
Captopril—LTA4H—cerebellum—multiple sclerosis	0.00125	0.0216	CbGeAlD
Captopril—MMP2—midbrain—multiple sclerosis	0.00114	0.0199	CbGeAlD
Captopril—MMP2—spinal cord—multiple sclerosis	0.00111	0.0194	CbGeAlD
Captopril—REN—nervous system—multiple sclerosis	0.00102	0.0178	CbGeAlD
Captopril—LTA4H—brain—multiple sclerosis	0.00101	0.0176	CbGeAlD
Captopril—REN—central nervous system—multiple sclerosis	0.000984	0.0171	CbGeAlD
Captopril—MMP9—spinal cord—multiple sclerosis	0.00097	0.0168	CbGeAlD
Captopril—REN—cerebellum—multiple sclerosis	0.000962	0.0167	CbGeAlD
Captopril—MMP2—nervous system—multiple sclerosis	0.000939	0.0163	CbGeAlD
Captopril—MMP2—central nervous system—multiple sclerosis	0.000904	0.0157	CbGeAlD
Captopril—F2—spinal cord—multiple sclerosis	0.000846	0.0147	CbGeAlD
Captopril—MMP9—nervous system—multiple sclerosis	0.000817	0.0142	CbGeAlD
Captopril—MMP9—central nervous system—multiple sclerosis	0.000787	0.0137	CbGeAlD
Captopril—REN—brain—multiple sclerosis	0.000781	0.0136	CbGeAlD
Captopril—MMP2—brain—multiple sclerosis	0.000718	0.0125	CbGeAlD
Captopril—F2—nervous system—multiple sclerosis	0.000713	0.0124	CbGeAlD
Captopril—F2—central nervous system—multiple sclerosis	0.000686	0.0119	CbGeAlD
Captopril—MMP9—brain—multiple sclerosis	0.000624	0.0108	CbGeAlD
Captopril—SLC22A6—brain—multiple sclerosis	0.000558	0.00969	CbGeAlD
Captopril—F2—brain—multiple sclerosis	0.000545	0.00947	CbGeAlD
Captopril—ACE—spinal cord—multiple sclerosis	0.000517	0.00898	CbGeAlD
Captopril—ACE—nervous system—multiple sclerosis	0.000435	0.00756	CbGeAlD
Captopril—ACE—central nervous system—multiple sclerosis	0.000419	0.00728	CbGeAlD
Captopril—CYP2D6—brainstem—multiple sclerosis	0.000407	0.00707	CbGeAlD
Captopril—ALB—brain—multiple sclerosis	0.000348	0.00604	CbGeAlD
Captopril—ACE—brain—multiple sclerosis	0.000333	0.00578	CbGeAlD
Captopril—MMP2—Dexamethasone—Methylprednisolone—multiple sclerosis	0.000312	0.105	CbGdCrCtD
Captopril—MMP2—Betamethasone—Methylprednisolone—multiple sclerosis	0.000312	0.105	CbGdCrCtD
Captopril—MMP2—Betamethasone—Dexamethasone—multiple sclerosis	0.000308	0.104	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Betamethasone—multiple sclerosis	0.000308	0.104	CbGdCrCtD
Captopril—MMP2—Betamethasone—Triamcinolone—multiple sclerosis	0.0003	0.101	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Triamcinolone—multiple sclerosis	0.0003	0.101	CbGdCrCtD
Captopril—MMP2—Betamethasone—Prednisone—multiple sclerosis	0.000285	0.0961	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Prednisone—multiple sclerosis	0.000285	0.0961	CbGdCrCtD
Captopril—ABCB1—retina—multiple sclerosis	0.000282	0.0049	CbGeAlD
Captopril—MMP2—Dexamethasone—Prednisolone—multiple sclerosis	0.000278	0.0938	CbGdCrCtD
Captopril—MMP2—Betamethasone—Prednisolone—multiple sclerosis	0.000278	0.0938	CbGdCrCtD
Captopril—CYP2D6—nervous system—multiple sclerosis	0.000213	0.0037	CbGeAlD
Captopril—CYP2D6—central nervous system—multiple sclerosis	0.000205	0.00356	CbGeAlD
Captopril—ABCB1—medulla oblongata—multiple sclerosis	0.000204	0.00354	CbGeAlD
Captopril—CYP2D6—cerebellum—multiple sclerosis	0.000201	0.00348	CbGeAlD
Captopril—ABCB1—midbrain—multiple sclerosis	0.000186	0.00324	CbGeAlD
Captopril—ABCB1—spinal cord—multiple sclerosis	0.000182	0.00316	CbGeAlD
Captopril—CYP2D6—brain—multiple sclerosis	0.000163	0.00283	CbGeAlD
Captopril—ABCB1—nervous system—multiple sclerosis	0.000153	0.00266	CbGeAlD
Captopril—Syncope—Prednisolone—multiple sclerosis	0.00015	0.00131	CcSEcCtD
Captopril—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00015	0.0013	CcSEcCtD
Captopril—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000149	0.00129	CcSEcCtD
Captopril—Somnolence—Mitoxantrone—multiple sclerosis	0.000148	0.00129	CcSEcCtD
Captopril—ABCB1—central nervous system—multiple sclerosis	0.000148	0.00256	CbGeAlD
Captopril—Loss of consciousness—Prednisolone—multiple sclerosis	0.000147	0.00128	CcSEcCtD
Captopril—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000147	0.00128	CcSEcCtD
Captopril—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000145	0.00126	CcSEcCtD
Captopril—Eosinophilia—Methotrexate—multiple sclerosis	0.000145	0.00126	CcSEcCtD
Captopril—ABCB1—cerebellum—multiple sclerosis	0.000144	0.00251	CbGeAlD
Captopril—Fatigue—Mitoxantrone—multiple sclerosis	0.000144	0.00125	CcSEcCtD
Captopril—Pancreatitis—Methotrexate—multiple sclerosis	0.000143	0.00125	CcSEcCtD
Captopril—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000143	0.00125	CcSEcCtD
Captopril—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000143	0.00124	CcSEcCtD
Captopril—Constipation—Mitoxantrone—multiple sclerosis	0.000143	0.00124	CcSEcCtD
Captopril—Alopecia—Betamethasone—multiple sclerosis	0.000142	0.00124	CcSEcCtD
Captopril—Alopecia—Dexamethasone—multiple sclerosis	0.000142	0.00124	CcSEcCtD
Captopril—Diarrhoea—Azathioprine—multiple sclerosis	0.000141	0.00123	CcSEcCtD
Captopril—Discomfort—Prednisolone—multiple sclerosis	0.000141	0.00123	CcSEcCtD
Captopril—Angioedema—Triamcinolone—multiple sclerosis	0.000141	0.00123	CcSEcCtD
Captopril—Angioedema—Methylprednisolone—multiple sclerosis	0.00014	0.00122	CcSEcCtD
Captopril—Hallucination—Prednisone—multiple sclerosis	0.000139	0.00121	CcSEcCtD
Captopril—Malaise—Triamcinolone—multiple sclerosis	0.000139	0.00121	CcSEcCtD
Captopril—Pancytopenia—Methotrexate—multiple sclerosis	0.000139	0.00121	CcSEcCtD
Captopril—Malaise—Methylprednisolone—multiple sclerosis	0.000139	0.00121	CcSEcCtD
Captopril—Syncope—Triamcinolone—multiple sclerosis	0.000138	0.0012	CcSEcCtD
Captopril—Syncope—Methylprednisolone—multiple sclerosis	0.000138	0.0012	CcSEcCtD
Captopril—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000137	0.0012	CcSEcCtD
Captopril—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000137	0.00119	CcSEcCtD
Captopril—Neutropenia—Methotrexate—multiple sclerosis	0.000137	0.00119	CcSEcCtD
Captopril—Dizziness—Azathioprine—multiple sclerosis	0.000136	0.00119	CcSEcCtD
Captopril—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000136	0.00119	CcSEcCtD
Captopril—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000135	0.00118	CcSEcCtD
Captopril—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000135	0.00118	CcSEcCtD
Captopril—Shock—Prednisolone—multiple sclerosis	0.000135	0.00117	CcSEcCtD
Captopril—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000134	0.00117	CcSEcCtD
Captopril—Cough—Triamcinolone—multiple sclerosis	0.000134	0.00117	CcSEcCtD
Captopril—Tachycardia—Prednisolone—multiple sclerosis	0.000133	0.00116	CcSEcCtD
Captopril—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000133	0.00116	CcSEcCtD
Captopril—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000132	0.00115	CcSEcCtD
Captopril—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000132	0.00115	CcSEcCtD
Captopril—Myalgia—Triamcinolone—multiple sclerosis	0.000131	0.00114	CcSEcCtD
Captopril—Vomiting—Azathioprine—multiple sclerosis	0.000131	0.00114	CcSEcCtD
Captopril—Myalgia—Methylprednisolone—multiple sclerosis	0.000131	0.00114	CcSEcCtD
Captopril—Arthralgia—Methylprednisolone—multiple sclerosis	0.000131	0.00114	CcSEcCtD
Captopril—Rash—Azathioprine—multiple sclerosis	0.00013	0.00113	CcSEcCtD
Captopril—Dermatitis—Azathioprine—multiple sclerosis	0.00013	0.00113	CcSEcCtD
Captopril—Flushing—Prednisone—multiple sclerosis	0.00013	0.00113	CcSEcCtD
Captopril—Ill-defined disorder—Betamethasone—multiple sclerosis	0.00013	0.00113	CcSEcCtD
Captopril—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.00013	0.00113	CcSEcCtD
Captopril—Discomfort—Triamcinolone—multiple sclerosis	0.00013	0.00113	CcSEcCtD
Captopril—Discomfort—Methylprednisolone—multiple sclerosis	0.000129	0.00113	CcSEcCtD
Captopril—Headache—Azathioprine—multiple sclerosis	0.000129	0.00113	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000129	0.00112	CcSEcCtD
Captopril—Dry mouth—Triamcinolone—multiple sclerosis	0.000128	0.00112	CcSEcCtD
Captopril—Renal failure—Methotrexate—multiple sclerosis	0.000128	0.00111	CcSEcCtD
Captopril—Angioedema—Betamethasone—multiple sclerosis	0.000128	0.00111	CcSEcCtD
Captopril—Angioedema—Dexamethasone—multiple sclerosis	0.000128	0.00111	CcSEcCtD
Captopril—Stomatitis—Methotrexate—multiple sclerosis	0.000127	0.00111	CcSEcCtD
Captopril—Confusional state—Methylprednisolone—multiple sclerosis	0.000126	0.0011	CcSEcCtD
Captopril—Malaise—Dexamethasone—multiple sclerosis	0.000126	0.0011	CcSEcCtD
Captopril—Malaise—Betamethasone—multiple sclerosis	0.000126	0.0011	CcSEcCtD
Captopril—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000126	0.0011	CcSEcCtD
Captopril—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000125	0.00109	CcSEcCtD
Captopril—Syncope—Dexamethasone—multiple sclerosis	0.000125	0.00109	CcSEcCtD
Captopril—Syncope—Betamethasone—multiple sclerosis	0.000125	0.00109	CcSEcCtD
Captopril—Shock—Triamcinolone—multiple sclerosis	0.000124	0.00108	CcSEcCtD
Captopril—Insomnia—Prednisolone—multiple sclerosis	0.000124	0.00108	CcSEcCtD
Captopril—Alopecia—Prednisone—multiple sclerosis	0.000124	0.00108	CcSEcCtD
Captopril—Shock—Methylprednisolone—multiple sclerosis	0.000123	0.00108	CcSEcCtD
Captopril—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000123	0.00107	CcSEcCtD
Captopril—Loss of consciousness—Betamethasone—multiple sclerosis	0.000123	0.00107	CcSEcCtD
Captopril—Paraesthesia—Prednisolone—multiple sclerosis	0.000123	0.00107	CcSEcCtD
Captopril—Tachycardia—Triamcinolone—multiple sclerosis	0.000123	0.00107	CcSEcCtD
Captopril—Nausea—Azathioprine—multiple sclerosis	0.000122	0.00107	CcSEcCtD
Captopril—Tachycardia—Methylprednisolone—multiple sclerosis	0.000122	0.00107	CcSEcCtD
Captopril—Agranulocytosis—Methotrexate—multiple sclerosis	0.000121	0.00106	CcSEcCtD
Captopril—Asthenia—Mitoxantrone—multiple sclerosis	0.00012	0.00104	CcSEcCtD
Captopril—Myalgia—Betamethasone—multiple sclerosis	0.000119	0.00104	CcSEcCtD
Captopril—Myalgia—Dexamethasone—multiple sclerosis	0.000119	0.00104	CcSEcCtD
Captopril—Discomfort—Dexamethasone—multiple sclerosis	0.000118	0.00102	CcSEcCtD
Captopril—Discomfort—Betamethasone—multiple sclerosis	0.000118	0.00102	CcSEcCtD
Captopril—Hypotension—Methylprednisolone—multiple sclerosis	0.000117	0.00102	CcSEcCtD
Captopril—ABCB1—brain—multiple sclerosis	0.000117	0.00204	CbGeAlD
Captopril—Hepatitis—Methotrexate—multiple sclerosis	0.000117	0.00102	CcSEcCtD
Captopril—Pharyngitis—Methotrexate—multiple sclerosis	0.000116	0.00101	CcSEcCtD
Captopril—Vision blurred—Prednisone—multiple sclerosis	0.000115	0.000999	CcSEcCtD
Captopril—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000115	0.000998	CcSEcCtD
Captopril—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000114	0.000996	CcSEcCtD
Captopril—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000114	0.000994	CcSEcCtD
Captopril—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000114	0.000994	CcSEcCtD
Captopril—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000114	0.000993	CcSEcCtD
Captopril—Insomnia—Triamcinolone—multiple sclerosis	0.000114	0.000991	CcSEcCtD
Captopril—Insomnia—Methylprednisolone—multiple sclerosis	0.000113	0.000988	CcSEcCtD
Captopril—Ill-defined disorder—Prednisone—multiple sclerosis	0.000113	0.000984	CcSEcCtD
Captopril—Paraesthesia—Triamcinolone—multiple sclerosis	0.000113	0.000984	CcSEcCtD
Captopril—Feeling abnormal—Prednisolone—multiple sclerosis	0.000113	0.000981	CcSEcCtD
Captopril—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000113	0.000981	CcSEcCtD
Captopril—Anaemia—Prednisone—multiple sclerosis	0.000113	0.00098	CcSEcCtD
Captopril—Shock—Betamethasone—multiple sclerosis	0.000112	0.000978	CcSEcCtD
Captopril—Shock—Dexamethasone—multiple sclerosis	0.000112	0.000978	CcSEcCtD
Captopril—Dyspnoea—Triamcinolone—multiple sclerosis	0.000112	0.000977	CcSEcCtD
Captopril—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000112	0.000973	CcSEcCtD
Captopril—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000112	0.000973	CcSEcCtD
Captopril—Tachycardia—Dexamethasone—multiple sclerosis	0.000111	0.00097	CcSEcCtD
Captopril—Tachycardia—Betamethasone—multiple sclerosis	0.000111	0.00097	CcSEcCtD
Captopril—Angioedema—Prednisone—multiple sclerosis	0.000111	0.000969	CcSEcCtD
Captopril—Dyspepsia—Triamcinolone—multiple sclerosis	0.000111	0.000964	CcSEcCtD
Captopril—Erythema multiforme—Methotrexate—multiple sclerosis	0.000111	0.000963	CcSEcCtD
Captopril—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00011	0.000962	CcSEcCtD
Captopril—Malaise—Prednisone—multiple sclerosis	0.00011	0.000956	CcSEcCtD
Captopril—Syncope—Prednisone—multiple sclerosis	0.000109	0.000951	CcSEcCtD
Captopril—Anorexia—Dexamethasone—multiple sclerosis	0.000109	0.000947	CcSEcCtD
Captopril—Anorexia—Betamethasone—multiple sclerosis	0.000109	0.000947	CcSEcCtD
Captopril—Fatigue—Triamcinolone—multiple sclerosis	0.000108	0.000944	CcSEcCtD
Captopril—Fatigue—Methylprednisolone—multiple sclerosis	0.000108	0.000942	CcSEcCtD
Captopril—Loss of consciousness—Prednisone—multiple sclerosis	0.000107	0.000932	CcSEcCtD
Captopril—Hypotension—Dexamethasone—multiple sclerosis	0.000107	0.000929	CcSEcCtD
Captopril—Hypotension—Betamethasone—multiple sclerosis	0.000107	0.000929	CcSEcCtD
Captopril—Vomiting—Mitoxantrone—multiple sclerosis	0.000106	0.000923	CcSEcCtD
Captopril—Rash—Mitoxantrone—multiple sclerosis	0.000105	0.000915	CcSEcCtD
Captopril—Dermatitis—Mitoxantrone—multiple sclerosis	0.000105	0.000915	CcSEcCtD
Captopril—Headache—Mitoxantrone—multiple sclerosis	0.000104	0.000909	CcSEcCtD
Captopril—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000104	0.000905	CcSEcCtD
Captopril—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000104	0.000905	CcSEcCtD
Captopril—Arthralgia—Prednisone—multiple sclerosis	0.000104	0.000903	CcSEcCtD
Captopril—Myalgia—Prednisone—multiple sclerosis	0.000104	0.000903	CcSEcCtD
Captopril—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000104	0.000903	CcSEcCtD
Captopril—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000103	0.000901	CcSEcCtD
Captopril—Alopecia—Methotrexate—multiple sclerosis	0.000103	0.0009	CcSEcCtD
Captopril—Insomnia—Dexamethasone—multiple sclerosis	0.000103	0.000899	CcSEcCtD
Captopril—Insomnia—Betamethasone—multiple sclerosis	0.000103	0.000899	CcSEcCtD
Captopril—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000103	0.000894	CcSEcCtD
Captopril—Paraesthesia—Betamethasone—multiple sclerosis	0.000102	0.000892	CcSEcCtD
Captopril—Paraesthesia—Dexamethasone—multiple sclerosis	0.000102	0.000892	CcSEcCtD
Captopril—Discomfort—Prednisone—multiple sclerosis	0.000102	0.000892	CcSEcCtD
Captopril—Dyspepsia—Betamethasone—multiple sclerosis	0.0001	0.000875	CcSEcCtD
Captopril—Dyspepsia—Dexamethasone—multiple sclerosis	0.0001	0.000875	CcSEcCtD
Captopril—Dysgeusia—Methotrexate—multiple sclerosis	9.96e-05	0.000868	CcSEcCtD
Captopril—Body temperature increased—Triamcinolone—multiple sclerosis	9.94e-05	0.000866	CcSEcCtD
Captopril—Anaphylactic shock—Prednisone—multiple sclerosis	9.94e-05	0.000865	CcSEcCtD
Captopril—Abdominal pain—Methylprednisolone—multiple sclerosis	9.92e-05	0.000864	CcSEcCtD
Captopril—Decreased appetite—Dexamethasone—multiple sclerosis	9.92e-05	0.000864	CcSEcCtD
Captopril—Decreased appetite—Betamethasone—multiple sclerosis	9.92e-05	0.000864	CcSEcCtD
Captopril—Nausea—Mitoxantrone—multiple sclerosis	9.9e-05	0.000862	CcSEcCtD
Captopril—Fatigue—Dexamethasone—multiple sclerosis	9.84e-05	0.000857	CcSEcCtD
Captopril—Fatigue—Betamethasone—multiple sclerosis	9.84e-05	0.000857	CcSEcCtD
Captopril—Shock—Prednisone—multiple sclerosis	9.77e-05	0.000852	CcSEcCtD
Captopril—Tachycardia—Prednisone—multiple sclerosis	9.7e-05	0.000845	CcSEcCtD
Captopril—Vision blurred—Methotrexate—multiple sclerosis	9.59e-05	0.000835	CcSEcCtD
Captopril—Anorexia—Prednisone—multiple sclerosis	9.47e-05	0.000825	CcSEcCtD
Captopril—Ill-defined disorder—Methotrexate—multiple sclerosis	9.44e-05	0.000822	CcSEcCtD
Captopril—Anaemia—Methotrexate—multiple sclerosis	9.4e-05	0.000819	CcSEcCtD
Captopril—Feeling abnormal—Dexamethasone—multiple sclerosis	9.4e-05	0.000819	CcSEcCtD
Captopril—Feeling abnormal—Betamethasone—multiple sclerosis	9.4e-05	0.000819	CcSEcCtD
Captopril—Gastrointestinal pain—Dexamethasone—multiple sclerosis	9.33e-05	0.000813	CcSEcCtD
Captopril—Gastrointestinal pain—Betamethasone—multiple sclerosis	9.33e-05	0.000813	CcSEcCtD
Captopril—Malaise—Methotrexate—multiple sclerosis	9.17e-05	0.000799	CcSEcCtD
Captopril—Musculoskeletal discomfort—Prednisone—multiple sclerosis	9.05e-05	0.000789	CcSEcCtD
Captopril—Dizziness—Prednisolone—multiple sclerosis	9.04e-05	0.000788	CcSEcCtD
Captopril—Asthenia—Triamcinolone—multiple sclerosis	9.02e-05	0.000786	CcSEcCtD
Captopril—Abdominal pain—Betamethasone—multiple sclerosis	9.02e-05	0.000786	CcSEcCtD
Captopril—Abdominal pain—Dexamethasone—multiple sclerosis	9.02e-05	0.000786	CcSEcCtD
Captopril—Body temperature increased—Dexamethasone—multiple sclerosis	9.02e-05	0.000786	CcSEcCtD
Captopril—Body temperature increased—Betamethasone—multiple sclerosis	9.02e-05	0.000786	CcSEcCtD
Captopril—Asthenia—Methylprednisolone—multiple sclerosis	9e-05	0.000784	CcSEcCtD
Captopril—Insomnia—Prednisone—multiple sclerosis	8.99e-05	0.000783	CcSEcCtD
Captopril—Paraesthesia—Prednisone—multiple sclerosis	8.92e-05	0.000777	CcSEcCtD
Captopril—Pruritus—Triamcinolone—multiple sclerosis	8.9e-05	0.000775	CcSEcCtD
Captopril—Cough—Methotrexate—multiple sclerosis	8.88e-05	0.000773	CcSEcCtD
Captopril—Pruritus—Methylprednisolone—multiple sclerosis	8.88e-05	0.000773	CcSEcCtD
Captopril—Dyspepsia—Prednisone—multiple sclerosis	8.75e-05	0.000762	CcSEcCtD
Captopril—Arthralgia—Methotrexate—multiple sclerosis	8.66e-05	0.000755	CcSEcCtD
Captopril—Myalgia—Methotrexate—multiple sclerosis	8.66e-05	0.000755	CcSEcCtD
Captopril—Chest pain—Methotrexate—multiple sclerosis	8.66e-05	0.000755	CcSEcCtD
Captopril—Decreased appetite—Prednisone—multiple sclerosis	8.64e-05	0.000752	CcSEcCtD
Captopril—Rash—Prednisolone—multiple sclerosis	8.62e-05	0.000751	CcSEcCtD
Captopril—Dermatitis—Prednisolone—multiple sclerosis	8.61e-05	0.00075	CcSEcCtD
Captopril—Diarrhoea—Methylprednisolone—multiple sclerosis	8.58e-05	0.000748	CcSEcCtD
Captopril—Fatigue—Prednisone—multiple sclerosis	8.57e-05	0.000746	CcSEcCtD
Captopril—Headache—Prednisolone—multiple sclerosis	8.57e-05	0.000746	CcSEcCtD
Captopril—Discomfort—Methotrexate—multiple sclerosis	8.56e-05	0.000745	CcSEcCtD
Captopril—Constipation—Prednisone—multiple sclerosis	8.5e-05	0.00074	CcSEcCtD
Captopril—Confusional state—Methotrexate—multiple sclerosis	8.37e-05	0.000729	CcSEcCtD
Captopril—Dizziness—Triamcinolone—multiple sclerosis	8.31e-05	0.000724	CcSEcCtD
Captopril—Anaphylactic shock—Methotrexate—multiple sclerosis	8.3e-05	0.000723	CcSEcCtD
Captopril—Dizziness—Methylprednisolone—multiple sclerosis	8.3e-05	0.000723	CcSEcCtD
Captopril—Feeling abnormal—Prednisone—multiple sclerosis	8.19e-05	0.000713	CcSEcCtD
Captopril—Asthenia—Betamethasone—multiple sclerosis	8.19e-05	0.000713	CcSEcCtD
Captopril—Asthenia—Dexamethasone—multiple sclerosis	8.19e-05	0.000713	CcSEcCtD
Captopril—Thrombocytopenia—Methotrexate—multiple sclerosis	8.13e-05	0.000708	CcSEcCtD
Captopril—Gastrointestinal pain—Prednisone—multiple sclerosis	8.12e-05	0.000708	CcSEcCtD
Captopril—Nausea—Prednisolone—multiple sclerosis	8.12e-05	0.000707	CcSEcCtD
Captopril—Pruritus—Betamethasone—multiple sclerosis	8.07e-05	0.000703	CcSEcCtD
Captopril—Pruritus—Dexamethasone—multiple sclerosis	8.07e-05	0.000703	CcSEcCtD
Captopril—Vomiting—Triamcinolone—multiple sclerosis	7.99e-05	0.000696	CcSEcCtD
Captopril—Vomiting—Methylprednisolone—multiple sclerosis	7.98e-05	0.000695	CcSEcCtD
Captopril—Rash—Triamcinolone—multiple sclerosis	7.93e-05	0.000691	CcSEcCtD
Captopril—Dermatitis—Triamcinolone—multiple sclerosis	7.92e-05	0.00069	CcSEcCtD
Captopril—Anorexia—Methotrexate—multiple sclerosis	7.91e-05	0.000689	CcSEcCtD
Captopril—Rash—Methylprednisolone—multiple sclerosis	7.91e-05	0.000689	CcSEcCtD
Captopril—Dermatitis—Methylprednisolone—multiple sclerosis	7.9e-05	0.000688	CcSEcCtD
Captopril—Headache—Triamcinolone—multiple sclerosis	7.88e-05	0.000686	CcSEcCtD
Captopril—Headache—Methylprednisolone—multiple sclerosis	7.86e-05	0.000685	CcSEcCtD
Captopril—Abdominal pain—Prednisone—multiple sclerosis	7.85e-05	0.000684	CcSEcCtD
Captopril—Body temperature increased—Prednisone—multiple sclerosis	7.85e-05	0.000684	CcSEcCtD
Captopril—Diarrhoea—Betamethasone—multiple sclerosis	7.81e-05	0.00068	CcSEcCtD
Captopril—Diarrhoea—Dexamethasone—multiple sclerosis	7.81e-05	0.00068	CcSEcCtD
Captopril—Hypotension—Methotrexate—multiple sclerosis	7.76e-05	0.000676	CcSEcCtD
Captopril—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	7.56e-05	0.000659	CcSEcCtD
Captopril—Dizziness—Dexamethasone—multiple sclerosis	7.54e-05	0.000657	CcSEcCtD
Captopril—Dizziness—Betamethasone—multiple sclerosis	7.54e-05	0.000657	CcSEcCtD
Captopril—Insomnia—Methotrexate—multiple sclerosis	7.51e-05	0.000654	CcSEcCtD
Captopril—Nausea—Triamcinolone—multiple sclerosis	7.47e-05	0.000651	CcSEcCtD
Captopril—Paraesthesia—Methotrexate—multiple sclerosis	7.46e-05	0.00065	CcSEcCtD
Captopril—Nausea—Methylprednisolone—multiple sclerosis	7.45e-05	0.000649	CcSEcCtD
Captopril—Dyspnoea—Methotrexate—multiple sclerosis	7.4e-05	0.000645	CcSEcCtD
Captopril—Somnolence—Methotrexate—multiple sclerosis	7.38e-05	0.000643	CcSEcCtD
Captopril—Dyspepsia—Methotrexate—multiple sclerosis	7.31e-05	0.000637	CcSEcCtD
Captopril—Vomiting—Betamethasone—multiple sclerosis	7.25e-05	0.000632	CcSEcCtD
Captopril—Vomiting—Dexamethasone—multiple sclerosis	7.25e-05	0.000632	CcSEcCtD
Captopril—Decreased appetite—Methotrexate—multiple sclerosis	7.22e-05	0.000629	CcSEcCtD
Captopril—Rash—Dexamethasone—multiple sclerosis	7.19e-05	0.000627	CcSEcCtD
Captopril—Rash—Betamethasone—multiple sclerosis	7.19e-05	0.000627	CcSEcCtD
Captopril—Dermatitis—Dexamethasone—multiple sclerosis	7.19e-05	0.000626	CcSEcCtD
Captopril—Dermatitis—Betamethasone—multiple sclerosis	7.19e-05	0.000626	CcSEcCtD
Captopril—Fatigue—Methotrexate—multiple sclerosis	7.16e-05	0.000624	CcSEcCtD
Captopril—Headache—Dexamethasone—multiple sclerosis	7.15e-05	0.000623	CcSEcCtD
Captopril—Headache—Betamethasone—multiple sclerosis	7.15e-05	0.000623	CcSEcCtD
Captopril—Asthenia—Prednisone—multiple sclerosis	7.13e-05	0.000621	CcSEcCtD
Captopril—Pruritus—Prednisone—multiple sclerosis	7.03e-05	0.000612	CcSEcCtD
Captopril—Feeling abnormal—Methotrexate—multiple sclerosis	6.84e-05	0.000596	CcSEcCtD
Captopril—Diarrhoea—Prednisone—multiple sclerosis	6.8e-05	0.000592	CcSEcCtD
Captopril—Gastrointestinal pain—Methotrexate—multiple sclerosis	6.79e-05	0.000591	CcSEcCtD
Captopril—Nausea—Dexamethasone—multiple sclerosis	6.78e-05	0.00059	CcSEcCtD
Captopril—Nausea—Betamethasone—multiple sclerosis	6.78e-05	0.00059	CcSEcCtD
Captopril—Dizziness—Prednisone—multiple sclerosis	6.57e-05	0.000572	CcSEcCtD
Captopril—Abdominal pain—Methotrexate—multiple sclerosis	6.56e-05	0.000572	CcSEcCtD
Captopril—Body temperature increased—Methotrexate—multiple sclerosis	6.56e-05	0.000572	CcSEcCtD
Captopril—Vomiting—Prednisone—multiple sclerosis	6.32e-05	0.00055	CcSEcCtD
Captopril—Rash—Prednisone—multiple sclerosis	6.26e-05	0.000546	CcSEcCtD
Captopril—Dermatitis—Prednisone—multiple sclerosis	6.26e-05	0.000545	CcSEcCtD
Captopril—Headache—Prednisone—multiple sclerosis	6.22e-05	0.000542	CcSEcCtD
Captopril—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	6.16e-05	0.000701	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CNR1—multiple sclerosis	6.11e-05	0.000695	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—RGS1—multiple sclerosis	6.08e-05	0.000691	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—MAPK1—multiple sclerosis	6.07e-05	0.00069	CbGpPWpGaD
Captopril—Asthenia—Methotrexate—multiple sclerosis	5.96e-05	0.000519	CcSEcCtD
Captopril—ALB—Folate Metabolism—CCL2—multiple sclerosis	5.9e-05	0.000671	CbGpPWpGaD
Captopril—Nausea—Prednisone—multiple sclerosis	5.9e-05	0.000514	CcSEcCtD
Captopril—MMP2—Axon guidance—MMP9—multiple sclerosis	5.88e-05	0.000669	CbGpPWpGaD
Captopril—Pruritus—Methotrexate—multiple sclerosis	5.87e-05	0.000512	CcSEcCtD
Captopril—ABCB1—Allograft Rejection—FAS—multiple sclerosis	5.81e-05	0.00066	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CXCL13—multiple sclerosis	5.8e-05	0.00066	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CCR1—multiple sclerosis	5.8e-05	0.00066	CbGpPWpGaD
Captopril—LTA4H—Metabolism—POMC—multiple sclerosis	5.8e-05	0.000659	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	5.77e-05	0.000656	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—GPR65—multiple sclerosis	5.76e-05	0.000655	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—TGFB1—multiple sclerosis	5.71e-05	0.000649	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	5.71e-05	0.000649	CbGpPWpGaD
Captopril—Diarrhoea—Methotrexate—multiple sclerosis	5.68e-05	0.000495	CcSEcCtD
Captopril—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.64e-05	0.000642	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	5.6e-05	0.000637	CbGpPWpGaD
Captopril—F2—Signaling Pathways—LINGO1—multiple sclerosis	5.57e-05	0.000634	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	5.5e-05	0.000626	CbGpPWpGaD
Captopril—F2—Hemostasis—ITGA4—multiple sclerosis	5.5e-05	0.000626	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CXCL10—multiple sclerosis	5.5e-05	0.000625	CbGpPWpGaD
Captopril—Dizziness—Methotrexate—multiple sclerosis	5.49e-05	0.000478	CcSEcCtD
Captopril—MMP9—Signaling Pathways—S1PR1—multiple sclerosis	5.47e-05	0.000622	CbGpPWpGaD
Captopril—F2—Hemostasis—IFNB1—multiple sclerosis	5.46e-05	0.000621	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—IL6—multiple sclerosis	5.38e-05	0.000611	CbGpPWpGaD
Captopril—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.38e-05	0.000611	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TYK2—multiple sclerosis	5.33e-05	0.000606	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GPC5—multiple sclerosis	5.32e-05	0.000605	CbGpPWpGaD
Captopril—LTA4H—Metabolism—ALB—multiple sclerosis	5.28e-05	0.000601	CbGpPWpGaD
Captopril—Vomiting—Methotrexate—multiple sclerosis	5.28e-05	0.00046	CcSEcCtD
Captopril—F2—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	5.27e-05	0.000599	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCL13—multiple sclerosis	5.27e-05	0.000599	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCR1—multiple sclerosis	5.27e-05	0.000599	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	5.25e-05	0.000597	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—IL6—multiple sclerosis	5.25e-05	0.000597	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	5.24e-05	0.000596	CbGpPWpGaD
Captopril—Rash—Methotrexate—multiple sclerosis	5.24e-05	0.000456	CcSEcCtD
Captopril—Dermatitis—Methotrexate—multiple sclerosis	5.23e-05	0.000456	CcSEcCtD
Captopril—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	5.21e-05	0.000593	CbGpPWpGaD
Captopril—Headache—Methotrexate—multiple sclerosis	5.2e-05	0.000453	CcSEcCtD
Captopril—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	5.1e-05	0.00058	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IFNG—multiple sclerosis	5.02e-05	0.000571	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.99e-05	0.000567	CbGpPWpGaD
Captopril—Nausea—Methotrexate—multiple sclerosis	4.93e-05	0.00043	CcSEcCtD
Captopril—MMP9—Axon guidance—TYK2—multiple sclerosis	4.9e-05	0.000557	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.9e-05	0.000557	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TAGAP—multiple sclerosis	4.83e-05	0.000549	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—CD80—multiple sclerosis	4.82e-05	0.000548	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.79e-05	0.000544	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.79e-05	0.000544	CbGpPWpGaD
Captopril—SLC15A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.76e-05	0.000541	CbGpPWpGaD
Captopril—MMP2—Axon guidance—MAPK1—multiple sclerosis	4.75e-05	0.000541	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CCL5—multiple sclerosis	4.73e-05	0.000538	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	4.69e-05	0.000533	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—IL6—multiple sclerosis	4.66e-05	0.00053	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RGS1—multiple sclerosis	4.65e-05	0.000529	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—POMC—multiple sclerosis	4.63e-05	0.000526	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—BCHE—multiple sclerosis	4.54e-05	0.000516	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—CCL2—multiple sclerosis	4.53e-05	0.000515	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	4.48e-05	0.00051	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL1B—multiple sclerosis	4.48e-05	0.000509	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL2—multiple sclerosis	4.46e-05	0.000507	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GPR65—multiple sclerosis	4.41e-05	0.000501	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	4.38e-05	0.000498	CbGpPWpGaD
Captopril—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.36e-05	0.000496	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.29e-05	0.000488	CbGpPWpGaD
Captopril—ALB—Hemostasis—PLEK—multiple sclerosis	4.29e-05	0.000487	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	4.28e-05	0.000487	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	4.27e-05	0.000486	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CCR5—multiple sclerosis	4.26e-05	0.000485	CbGpPWpGaD
Captopril—F2—Signaling Pathways—S1PR1—multiple sclerosis	4.22e-05	0.00048	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—MMP9—multiple sclerosis	4.2e-05	0.000477	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	4.17e-05	0.000474	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—POMC—multiple sclerosis	4.16e-05	0.000473	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GPC5—multiple sclerosis	4.11e-05	0.000467	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—CCL2—multiple sclerosis	4.07e-05	0.000463	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCR1—multiple sclerosis	4.03e-05	0.000459	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCL13—multiple sclerosis	4.03e-05	0.000459	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	3.99e-05	0.000454	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	3.99e-05	0.000453	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PTGER4—multiple sclerosis	3.98e-05	0.000453	CbGpPWpGaD
Captopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	3.88e-05	0.000441	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CXCR3—multiple sclerosis	3.84e-05	0.000437	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	3.81e-05	0.000433	CbGpPWpGaD
Captopril—F2—Hemostasis—IL2RA—multiple sclerosis	3.76e-05	0.000427	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCL3—multiple sclerosis	3.76e-05	0.000427	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—TGFB1—multiple sclerosis	3.75e-05	0.000426	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CCR2—multiple sclerosis	3.74e-05	0.000425	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—STAT3—multiple sclerosis	3.73e-05	0.000424	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.71e-05	0.000422	CbGpPWpGaD
Captopril—MMP2—Axon guidance—IL6—multiple sclerosis	3.65e-05	0.000415	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PTGER4—multiple sclerosis	3.61e-05	0.000411	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RGS1—multiple sclerosis	3.59e-05	0.000408	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	3.56e-05	0.000404	CbGpPWpGaD
Captopril—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.53e-05	0.000402	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TYK2—multiple sclerosis	3.5e-05	0.000398	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCR3—multiple sclerosis	3.49e-05	0.000397	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TGFB1—multiple sclerosis	3.46e-05	0.000393	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CNR1—multiple sclerosis	3.45e-05	0.000393	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GPR65—multiple sclerosis	3.4e-05	0.000387	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	3.4e-05	0.000386	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCR2—multiple sclerosis	3.4e-05	0.000386	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—MAPK1—multiple sclerosis	3.39e-05	0.000386	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL2—multiple sclerosis	3.38e-05	0.000385	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.35e-05	0.000381	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	3.34e-05	0.00038	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	3.33e-05	0.000379	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—POMC—multiple sclerosis	3.33e-05	0.000379	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	3.27e-05	0.000372	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CCL2—multiple sclerosis	3.26e-05	0.000371	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.25e-05	0.00037	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TNF—multiple sclerosis	3.25e-05	0.000369	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TNF—multiple sclerosis	3.23e-05	0.000367	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	3.22e-05	0.000366	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CNR1—multiple sclerosis	3.13e-05	0.000356	CbGpPWpGaD
Captopril—MMP9—Axon guidance—MAPK1—multiple sclerosis	3.12e-05	0.000355	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCL13—multiple sclerosis	3.11e-05	0.000354	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCR1—multiple sclerosis	3.11e-05	0.000354	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CXCL10—multiple sclerosis	3.11e-05	0.000353	CbGpPWpGaD
Captopril—ALB—Metabolism—SRM—multiple sclerosis	3.03e-05	0.000344	CbGpPWpGaD
Captopril—ALB—Hemostasis—SELE—multiple sclerosis	3.02e-05	0.000343	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—TGFB1—multiple sclerosis	2.98e-05	0.000339	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.93e-05	0.000333	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	2.89e-05	0.000329	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCL3—multiple sclerosis	2.87e-05	0.000327	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.87e-05	0.000326	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	2.84e-05	0.000323	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCL10—multiple sclerosis	2.82e-05	0.000321	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PTGER4—multiple sclerosis	2.77e-05	0.000315	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PGR—multiple sclerosis	2.72e-05	0.00031	CbGpPWpGaD
Captopril—F2—Hemostasis—ALB—multiple sclerosis	2.72e-05	0.000309	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CCL5—multiple sclerosis	2.68e-05	0.000304	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCR3—multiple sclerosis	2.67e-05	0.000304	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SRM—multiple sclerosis	2.65e-05	0.000301	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CD28—multiple sclerosis	2.65e-05	0.000301	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.64e-05	0.0003	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL6—multiple sclerosis	2.62e-05	0.000298	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—IL6—multiple sclerosis	2.61e-05	0.000296	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCR2—multiple sclerosis	2.6e-05	0.000296	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.59e-05	0.000295	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	2.58e-05	0.000293	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.57e-05	0.000292	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	2.57e-05	0.000292	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SRM—multiple sclerosis	2.5e-05	0.000284	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.46e-05	0.00028	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—STAT3—multiple sclerosis	2.45e-05	0.000278	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCL5—multiple sclerosis	2.43e-05	0.000276	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.42e-05	0.000275	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CCR5—multiple sclerosis	2.41e-05	0.000274	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CNR1—multiple sclerosis	2.4e-05	0.000273	CbGpPWpGaD
Captopril—MMP9—Axon guidance—IL6—multiple sclerosis	2.4e-05	0.000273	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—IL2RA—multiple sclerosis	2.38e-05	0.00027	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—POMC—multiple sclerosis	2.34e-05	0.000267	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.31e-05	0.000263	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CCL2—multiple sclerosis	2.29e-05	0.000261	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.27e-05	0.000258	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TGFB1—multiple sclerosis	2.27e-05	0.000258	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—MAPK1—multiple sclerosis	2.23e-05	0.000253	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCL3—multiple sclerosis	2.22e-05	0.000252	CbGpPWpGaD
Captopril—F2—Hemostasis—IL2—multiple sclerosis	2.2e-05	0.000251	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCR5—multiple sclerosis	2.19e-05	0.000249	CbGpPWpGaD
Captopril—ALB—Hemostasis—ITGA4—multiple sclerosis	2.18e-05	0.000248	CbGpPWpGaD
Captopril—ALB—Hemostasis—IFNB1—multiple sclerosis	2.17e-05	0.000246	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCL10—multiple sclerosis	2.16e-05	0.000246	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL2RA—multiple sclerosis	2.16e-05	0.000245	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTGER4—multiple sclerosis	2.14e-05	0.000243	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP27B1—multiple sclerosis	2.13e-05	0.000242	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP24A1—multiple sclerosis	2.13e-05	0.000242	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TNF—multiple sclerosis	2.12e-05	0.000241	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PGR—multiple sclerosis	2.1e-05	0.000239	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.08e-05	0.000237	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	2.08e-05	0.000237	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCR3—multiple sclerosis	2.06e-05	0.000235	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CD28—multiple sclerosis	2.04e-05	0.000232	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCR2—multiple sclerosis	2.01e-05	0.000228	CbGpPWpGaD
Captopril—ALB—Metabolism—GPC5—multiple sclerosis	1.95e-05	0.000222	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CD86—multiple sclerosis	1.89e-05	0.000215	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—POMC—multiple sclerosis	1.88e-05	0.000214	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.87e-05	0.000212	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.87e-05	0.000212	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCL5—multiple sclerosis	1.86e-05	0.000211	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CNR1—multiple sclerosis	1.85e-05	0.000211	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.8e-05	0.000204	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.76e-05	0.0002	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.76e-05	0.0002	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SPP1—multiple sclerosis	1.72e-05	0.000196	CbGpPWpGaD
Captopril—F2—Hemostasis—TGFB1—multiple sclerosis	1.72e-05	0.000195	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—POMC—multiple sclerosis	1.71e-05	0.000195	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—IL6—multiple sclerosis	1.71e-05	0.000194	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GPC5—multiple sclerosis	1.71e-05	0.000194	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.7e-05	0.000193	CbGpPWpGaD
Captopril—F2—Hemostasis—MAPK1—multiple sclerosis	1.69e-05	0.000192	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCR5—multiple sclerosis	1.67e-05	0.00019	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCL2—multiple sclerosis	1.67e-05	0.00019	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCL10—multiple sclerosis	1.67e-05	0.00019	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL2RA—multiple sclerosis	1.65e-05	0.000188	CbGpPWpGaD
Captopril—ALB—Metabolism—RRM1—multiple sclerosis	1.62e-05	0.000184	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.61e-05	0.000183	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—APOE—multiple sclerosis	1.52e-05	0.000173	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—TYK2—multiple sclerosis	1.52e-05	0.000173	CbGpPWpGaD
Captopril—ALB—Hemostasis—IL2RA—multiple sclerosis	1.49e-05	0.00017	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CD86—multiple sclerosis	1.46e-05	0.000166	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCL5—multiple sclerosis	1.44e-05	0.000163	CbGpPWpGaD
Captopril—ABCB1—Metabolism—RRM1—multiple sclerosis	1.42e-05	0.000161	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—IL2—multiple sclerosis	1.39e-05	0.000158	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CD80—multiple sclerosis	1.38e-05	0.000157	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.33e-05	0.000152	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SPP1—multiple sclerosis	1.33e-05	0.000151	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.32e-05	0.00015	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—POMC—multiple sclerosis	1.31e-05	0.000149	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.31e-05	0.000149	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.3e-05	0.000148	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.3e-05	0.000148	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCR5—multiple sclerosis	1.29e-05	0.000147	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCL2—multiple sclerosis	1.28e-05	0.000146	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.28e-05	0.000145	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL2RA—multiple sclerosis	1.27e-05	0.000145	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL2—multiple sclerosis	1.26e-05	0.000144	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.25e-05	0.000143	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.22e-05	0.000138	CbGpPWpGaD
Captopril—F2—Signaling Pathways—APOE—multiple sclerosis	1.18e-05	0.000134	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TYK2—multiple sclerosis	1.16e-05	0.000132	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.08e-05	0.000122	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CD80—multiple sclerosis	1.06e-05	0.000121	CbGpPWpGaD
Captopril—F2—Signaling Pathways—POMC—multiple sclerosis	1.01e-05	0.000115	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCL2—multiple sclerosis	9.89e-06	0.000112	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL2—multiple sclerosis	9.67e-06	0.00011	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—MAPK1—multiple sclerosis	9.67e-06	0.00011	CbGpPWpGaD
Captopril—ALB—Metabolism—BCHE—multiple sclerosis	9.28e-06	0.000106	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TYK2—multiple sclerosis	8.98e-06	0.000102	CbGpPWpGaD
Captopril—ALB—Hemostasis—IL2—multiple sclerosis	8.74e-06	9.94e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.18e-06	9.3e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—STAT3—multiple sclerosis	8.14e-06	9.26e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—BCHE—multiple sclerosis	8.13e-06	9.24e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—BCHE—multiple sclerosis	7.66e-06	8.71e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MYC—multiple sclerosis	7.56e-06	8.6e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TGFB1—multiple sclerosis	7.55e-06	8.58e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL2—multiple sclerosis	7.47e-06	8.49e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL6—multiple sclerosis	7.43e-06	8.45e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAPK1—multiple sclerosis	7.4e-06	8.42e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MMP9—multiple sclerosis	7.07e-06	8.04e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TGFB1—multiple sclerosis	6.82e-06	7.76e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—MAPK1—multiple sclerosis	6.69e-06	7.61e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—STAT3—multiple sclerosis	6.29e-06	7.15e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MYC—multiple sclerosis	5.84e-06	6.64e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TGFB1—multiple sclerosis	5.83e-06	6.63e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAPK1—multiple sclerosis	5.71e-06	6.5e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL6—multiple sclerosis	5.69e-06	6.47e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—APOE—multiple sclerosis	5.58e-06	6.35e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—APOE—multiple sclerosis	4.89e-06	5.56e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—POMC—multiple sclerosis	4.79e-06	5.45e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—APOE—multiple sclerosis	4.61e-06	5.24e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL6—multiple sclerosis	4.39e-06	4.99e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—POMC—multiple sclerosis	4.2e-06	4.78e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—POMC—multiple sclerosis	3.96e-06	4.5e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALB—multiple sclerosis	3.83e-06	4.36e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALB—multiple sclerosis	3.61e-06	4.1e-05	CbGpPWpGaD
